The cloning and isolation of the human factor vm (FVIII) gene in the m
id-1980s has Lead to 10 years of increasing understanding of the genet
ic and hence the molecular basis of haemophilia A. These studies are n
ot only of enormous potential benefit for accurate carrier detection a
nd prenatal diagnosis in families with haemophilia A, but provide insi
ghts into the relationships between genetic defects and their clinical
manifestations. These latter studies not only explain and even predic
t the severity of the disease but may also help towards a better under
standing of the basis of inhibitor development.